Brain, Vol. 115, No. 5, 1291-1302, 1992
© 1992 Guarantors of Brain
research-article |
MOTOR NERVE INEXCITABILITY IN GUILLAIN-BARRÉ SYNDROME
THE SPECTRUM OF DISTAL CONDUCTION BLOCK AND AXONAL DEGENERATION
1Department of Neurology and the Clinical Neurophysiology Laboratory, Massachusetts General Hospital Boston 2Department of Neurology, Temple University Hospital Philadelphia 3Department of Neurology, the University of Texas Health Science Center at Houston Texas, USA
Correspondence to:
Correspondence to Didier Cros, MD, Clinical Neurophysiology Laboratory, Bigelow 12, Massachusetts General Hospital, Fruit Street, Boston, MA 02114, USA
We studied 34 patients with the Guillain-Barré syndrome (GBS) to clarify the clinical significance of inexcitable motor nerves and of low amplitude compound muscle action potentials (CMAPs). The patients were subdivided into two groups. Group 1 included eight patients who had electrically inexcitable motor nerves within 2 wks of the first symptom (Two patients without extensive conduction studies had only one inexcitable motor nerve.) The outcome in this group at 1 yr varied from complete recovery (five patients) to severe motor sequelae (three patients). Group1 included 26 patients who had two electrophysiological assessments, and in whom the serial changes in CMAP amplitudes were analysed and correlated to outcome. Fourteen of these 26 sets of serial studies were performed within 1 mth. Twelve of 26 patients in Group 2 showed decrease in the amplitude of CMAPs between serial studies; only six of these had a good outcome at 1 yr. Nine of 26 patients showed increase in CMAP amplitude between serial studies, of these eight had a good clinical outcome.
Low-amplitude CMAPs or inexcitable motor nerves in the initial stages of GBS are due to distal pathology of the motor axons, either distal conduction block or axonal degeneration. The nature of these changes cannot be predicted by the results of the initial electrophysiological evaluation, including the presence or absence of active denervation. However, improvement of CMAP amplitude on sequential studies suggests a good outcome at 1 yr. We believe that, in the absence of a biological marker for GBS, individualization of an ‘axonal variant’ of the syndrome is not warranted at the present time.
Received June 20, 1991. Revised February 2, 1992. Accepted April 30, 1992.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. J. Triggs and D. Cros Case 40-2007 -- A 38-Year-Old Man with Weakness in the Hands N. Engl. J. Med., December 27, 2007; 357(26): 2707 - 2715. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sharshar, M.-C. Durand, J.-P. Lefaucheur, F. Lofaso, J.-C. Raphael, R. K. Gherardi, and A. Creange MMP-9 correlates with electrophysiologic abnormalities in Guillain-Barre syndrome Neurology, November 26, 2002; 59(10): 1649 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Berciano, A. Garcia, J. Figols, R. Munoz, M. T. Berciano, and M. Lafarga Perineurium contributes to axonal damage in acute inflammatory demyelinating polyneuropathy Neurology, August 22, 2000; 55(4): 552 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Lu, K. A. Sheikh, H. S. Wu, J. Zhang, Z. F. Jiang, D. R. Cornblath, G. M. McKhann, A. K. Asbury, J. W. Griffin, and T. W. Ho Physiologic-pathologic correlation in Guillain-Barre syndrome in children Neurology, January 11, 2000; 54(1): 33 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Ropper, D. P. Cros, and D. E. Palmer-Toy Case 39-1999- A 74-Year-Old Woman with Acute, Progressive Paralysis after Diarrhea for One Week N. Engl. J. Med., December 23, 1999; 341(26): 1996 - 2003. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Nachamkin, B. M. Allos, and T. Ho Campylobacter Species and Guillain-Barre Syndrome Clin. Microbiol. Rev., July 1, 1998; 11(3): 555 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Gominak and D. P. Cros Case 13-1998- A 23-Year-Old Man with Progressive Weakness and Paresthesias N. Engl. J. Med., April 23, 1998; 338(17): 1212 - 1219. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bingisser, R. Speich, A. Fontana, J. Gmur, B. Vogel, and T. Landis Lupus Erythematosus and Miller-Fisher Syndrome Arch Neurol, August 1, 1994; 51(8): 828 - 830. [Abstract] [PDF]
|
|